These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 12699985)

  • 1. Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries.
    Omata M; Kanda T; Yokosuka O; Crawford D; Al-Mahtab M; Wei L; Ibrahim A; Lau GK; Sharma BC; Hamid SS; Chuang WL; Dokmeci AK
    Hepatol Int; 2015 Oct; 9(4):486-507. PubMed ID: 25941137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India.
    Puri P; Anand AC; Saraswat VA; Acharya SK; Dhiman RK; Aggarwal R; Singh SP; Amarapurkar D; Arora A; Chhabra M; Chetri K; Choudhuri G; Dixit VK; Duseja A; Jain AK; Kapoorz D; Kar P; Koshy A; Kumar A; Madan K; Misra SP; Prasad MV; Nagral A; Puri AS; Jeyamani R; Saigal S; Sarin SK; Shah S; Sharma PK; Sood A; Thareja S; Wadhawan M
    J Clin Exp Hepatol; 2014 Jun; 4(2):106-16. PubMed ID: 25755548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of substance abuse and hepatitis C virus infection and co-infections in India.
    Basu D
    J Neuroimmune Pharmacol; 2010 Dec; 5(4):496-506. PubMed ID: 20559752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross border HIV epidemic among injecting drug users of Himalayan West Bengal.
    Sarkar K; Bal B; Mukherjee R; Niyogi SK; Saha MK; Bhattacharya SK
    Eur J Epidemiol; 2005; 20(4):373-4. PubMed ID: 15971511
    [No Abstract]   [Full Text] [Related]  

  • 5. Remarkable difference in the mode of HCV transmission among haemodialysis patients and IVDAs.
    Alavian SM; Hajarizadeh B
    Gut; 2004 Jul; 53(7):1057. PubMed ID: 15194666
    [No Abstract]   [Full Text] [Related]  

  • 6. Remarkable resemblance in the mode of transmission of HCV infection among haemodialysis patients and IVDAs.
    Saxena AK; Panhotra BR; Al-Ghamdi AM
    Gut; 2003 Nov; 52(11):1656-7. PubMed ID: 14570740
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C infection among injecting drug users in Scotland: stemming the flow.
    Goldberg D; Taylor A; Hutchinson S; McMenamin J
    Scott Med J; 2000 Oct; 45(5):131-2. PubMed ID: 11130293
    [No Abstract]   [Full Text] [Related]  

  • 8. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ongoing HIV and viral hepatitis infections in IDUs across the EU, 2001-2005.
    Wiessing L; Nardone A
    Euro Surveill; 2006 Nov; 11(11):E061123.2. PubMed ID: 17213556
    [No Abstract]   [Full Text] [Related]  

  • 10. High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia.
    Uusküla A; McNutt LA; Dehovitz J; Fischer K; Heimer R
    Int J STD AIDS; 2007 Jan; 18(1):41-6. PubMed ID: 17326862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users.
    Vassilev ZP; Hagan H; Lyubenova A; Tomov N; Vasilev G; Krasteva D; Des Jarlais DC
    Int J STD AIDS; 2006 Sep; 17(9):621-6. PubMed ID: 16942654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assessment of an HIV prevention intervention among people who inject drugs in the states of Manipur and Nagaland, India.
    Goswami P; Medhi GK; Armstrong G; Setia MS; Mathew S; Thongamba G; Ramakrishnan L; George B; Singh RK; Paranjape RS; Mahanta J
    Int J Drug Policy; 2014 Sep; 25(5):853-64. PubMed ID: 24925819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010.
    Wiessing L; Likatavicius G; Hedrich D; Guarita B; van de Laar MJ; Vicente J
    Euro Surveill; 2011 Dec; 16(48):. PubMed ID: 22172300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid spread of hepatitis C and needle exchange programme in Kolkata, India.
    Sarkar K; Mitra S; Bal B; Chakraborty S; Bhattacharya SK
    Lancet; 2003 Apr; 361(9365):1301-2. PubMed ID: 12699985
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.